Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade

J. B. Bedotto, R. G. Gay, S. D. Graham, E. Morkin, Steven Goldman

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

This study was designed to determine whether thyroid hormone (T4) produces cardiac hypertrophy and alters ventricular function by direct effects on the heart or by alterations in adrenergic stimulation or changes in the peripheral circulation. Rats were treated with captopril (4 mg/ml of drinking water), propranolol (0.5 mg/ml of drinking water), hydralazine (80 mg/l of drinking water) or the combination of captopril and propranolol with and without T4 (15 μg/100 g b.w. i.p.). After 10 days, T4 increased (P<.01) heart rate, left ventricular (LV) dP/dt and LV weight/body weight, but did not alter LV systolic pressure (SP) or end-diastolic pressure (EDP). Compared to treatment with T4 alone, captopril plus T4 decreased LV SP (P<.05) and LV EDP (P<.01); however, heart rate, LV dP/dt and LV weight/body weight were unchanged. Treatment with T4 plus propranolol decreased heart rate and LV EDP (P<.05) compared to T4 alone; however, LV SP, LV dP/dt and LV weight/body weight were unchanged (P>.05). Hydralazine did not alter (P>.05) heart rate, LV SP, LV EDP or prevent the development of increased LV weight/body weight when given with T4; however, LV dP/dt was slightly decreased (P<.05). Treatment with the combination of captopril and propranolol did not alter (P>.05) heart rate, LV SP, LV EDP or LV dP/dt and also failed to prevent the development of increased LV weight/body weight and LV dP/dt when given with T4. Thus, LV hypertrophy and augmentation of LV function were produced by T4 treatment despite beta adrenoceptor blockade with propranolol, alteration of cardiac load with captopril or hydralazine and the combination of beta adrenoceptor blockade and captopril.

Original languageEnglish (US)
Pages (from-to)632-636
Number of pages5
JournalJournal of Pharmacology and Experimental Therapeutics
Volume248
Issue number2
StatePublished - 1989
Externally publishedYes

Fingerprint

Captopril
Cardiomegaly
Thyroid Hormones
Hydralazine
Adrenergic Receptors
Propranolol
Drinking Water
Heart Rate
Body Weight
Weights and Measures
Ventricular Function
Thyroxine
Adrenergic Agents
Hypertrophy

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade. / Bedotto, J. B.; Gay, R. G.; Graham, S. D.; Morkin, E.; Goldman, Steven.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 248, No. 2, 1989, p. 632-636.

Research output: Contribution to journalArticle

@article{07c6f6c78b84421f925b26e30de4f7ae,
title = "Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade",
abstract = "This study was designed to determine whether thyroid hormone (T4) produces cardiac hypertrophy and alters ventricular function by direct effects on the heart or by alterations in adrenergic stimulation or changes in the peripheral circulation. Rats were treated with captopril (4 mg/ml of drinking water), propranolol (0.5 mg/ml of drinking water), hydralazine (80 mg/l of drinking water) or the combination of captopril and propranolol with and without T4 (15 μg/100 g b.w. i.p.). After 10 days, T4 increased (P<.01) heart rate, left ventricular (LV) dP/dt and LV weight/body weight, but did not alter LV systolic pressure (SP) or end-diastolic pressure (EDP). Compared to treatment with T4 alone, captopril plus T4 decreased LV SP (P<.05) and LV EDP (P<.01); however, heart rate, LV dP/dt and LV weight/body weight were unchanged. Treatment with T4 plus propranolol decreased heart rate and LV EDP (P<.05) compared to T4 alone; however, LV SP, LV dP/dt and LV weight/body weight were unchanged (P>.05). Hydralazine did not alter (P>.05) heart rate, LV SP, LV EDP or prevent the development of increased LV weight/body weight when given with T4; however, LV dP/dt was slightly decreased (P<.05). Treatment with the combination of captopril and propranolol did not alter (P>.05) heart rate, LV SP, LV EDP or LV dP/dt and also failed to prevent the development of increased LV weight/body weight and LV dP/dt when given with T4. Thus, LV hypertrophy and augmentation of LV function were produced by T4 treatment despite beta adrenoceptor blockade with propranolol, alteration of cardiac load with captopril or hydralazine and the combination of beta adrenoceptor blockade and captopril.",
author = "Bedotto, {J. B.} and Gay, {R. G.} and Graham, {S. D.} and E. Morkin and Steven Goldman",
year = "1989",
language = "English (US)",
volume = "248",
pages = "632--636",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade

AU - Bedotto, J. B.

AU - Gay, R. G.

AU - Graham, S. D.

AU - Morkin, E.

AU - Goldman, Steven

PY - 1989

Y1 - 1989

N2 - This study was designed to determine whether thyroid hormone (T4) produces cardiac hypertrophy and alters ventricular function by direct effects on the heart or by alterations in adrenergic stimulation or changes in the peripheral circulation. Rats were treated with captopril (4 mg/ml of drinking water), propranolol (0.5 mg/ml of drinking water), hydralazine (80 mg/l of drinking water) or the combination of captopril and propranolol with and without T4 (15 μg/100 g b.w. i.p.). After 10 days, T4 increased (P<.01) heart rate, left ventricular (LV) dP/dt and LV weight/body weight, but did not alter LV systolic pressure (SP) or end-diastolic pressure (EDP). Compared to treatment with T4 alone, captopril plus T4 decreased LV SP (P<.05) and LV EDP (P<.01); however, heart rate, LV dP/dt and LV weight/body weight were unchanged. Treatment with T4 plus propranolol decreased heart rate and LV EDP (P<.05) compared to T4 alone; however, LV SP, LV dP/dt and LV weight/body weight were unchanged (P>.05). Hydralazine did not alter (P>.05) heart rate, LV SP, LV EDP or prevent the development of increased LV weight/body weight when given with T4; however, LV dP/dt was slightly decreased (P<.05). Treatment with the combination of captopril and propranolol did not alter (P>.05) heart rate, LV SP, LV EDP or LV dP/dt and also failed to prevent the development of increased LV weight/body weight and LV dP/dt when given with T4. Thus, LV hypertrophy and augmentation of LV function were produced by T4 treatment despite beta adrenoceptor blockade with propranolol, alteration of cardiac load with captopril or hydralazine and the combination of beta adrenoceptor blockade and captopril.

AB - This study was designed to determine whether thyroid hormone (T4) produces cardiac hypertrophy and alters ventricular function by direct effects on the heart or by alterations in adrenergic stimulation or changes in the peripheral circulation. Rats were treated with captopril (4 mg/ml of drinking water), propranolol (0.5 mg/ml of drinking water), hydralazine (80 mg/l of drinking water) or the combination of captopril and propranolol with and without T4 (15 μg/100 g b.w. i.p.). After 10 days, T4 increased (P<.01) heart rate, left ventricular (LV) dP/dt and LV weight/body weight, but did not alter LV systolic pressure (SP) or end-diastolic pressure (EDP). Compared to treatment with T4 alone, captopril plus T4 decreased LV SP (P<.05) and LV EDP (P<.01); however, heart rate, LV dP/dt and LV weight/body weight were unchanged. Treatment with T4 plus propranolol decreased heart rate and LV EDP (P<.05) compared to T4 alone; however, LV SP, LV dP/dt and LV weight/body weight were unchanged (P>.05). Hydralazine did not alter (P>.05) heart rate, LV SP, LV EDP or prevent the development of increased LV weight/body weight when given with T4; however, LV dP/dt was slightly decreased (P<.05). Treatment with the combination of captopril and propranolol did not alter (P>.05) heart rate, LV SP, LV EDP or LV dP/dt and also failed to prevent the development of increased LV weight/body weight and LV dP/dt when given with T4. Thus, LV hypertrophy and augmentation of LV function were produced by T4 treatment despite beta adrenoceptor blockade with propranolol, alteration of cardiac load with captopril or hydralazine and the combination of beta adrenoceptor blockade and captopril.

UR - http://www.scopus.com/inward/record.url?scp=0024564951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024564951&partnerID=8YFLogxK

M3 - Article

C2 - 2537405

AN - SCOPUS:0024564951

VL - 248

SP - 632

EP - 636

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -